• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西的 COVID-19 诊断和住院情况:一项全国性调查(Covitel,2022 年)。

COVID-19 diagnosis and hospital admissions in Brazil: a countrywide survey (Covitel, 2022).

机构信息

Universidade Federal de Minas Gerais, School of Medicine, Graduate Program in Public Health - Belo Horizonte (MG), Brazil.

Vital Strategies - São Paulo (SP), Brazil.

出版信息

Rev Bras Epidemiol. 2024 Nov 22;27:e240052. doi: 10.1590/1980-549720240052. eCollection 2024.

DOI:10.1590/1980-549720240052
Abstract

OBJECTIVE

To estimate the prevalence of COVID-19 diagnosis and hospital admissions, and to evaluate their correlates in a nationwide Brazilian sample.

METHODS

A cross-sectional study was carried out with secondary data from the Telephone Survey of Risk Factors for Chronic Noncommunicable Diseases in Times of Pandemic - Covitel 2022. The Covitel study uses cluster sampling, carried out through random digit dialing on landlines and cell phones, among people aged 18 years or over. The outcome of the "diagnosis of COVID-19" was based on a self-report of a confirmed case through laboratory tests or medical diagnoses. Those who reported COVID-19 were asked about the need for hospital admission due to COVID-19. Independent variables included sex, age, level of education, region, comorbidity, private health insurance plan, self-rated health, and employment status. The odds ratio was estimated using logistic regression models considering the complex sample design.

RESULTS

From the sample of 9000 people, the prevalence of COVID-19 diagnosis was 25.4% (95%CI 23.8-27.1%), ranging from 23.0% (95%CI 20.0-26.3%) in the Northeast region to 28.5% (95%CI 25.3-31.7%) in the South region. Middle-aged adults (35-44 years old) had the highest prevalence of COVID-19 diagnosis. The higher the level of education, the higher the prevalence of COVID-19 diagnosis.

CONCLUSION

The prevalence of COVID-19 diagnosis is markedly different from that of SARS-CoV-2 infection at the population level. Socioeconomic differences in access to testing are the likely explanation. Older adults and people with comorbidities were more likely to be admitted to hospital due to COVID-19 in Brazil.

摘要

目的

估计 COVID-19 诊断和住院的流行率,并评估巴西全国样本中这些因素的相关性。

方法

这是一项使用来自大流行期间慢性非传染性疾病危险因素的电话调查 - Covitel 2022 的二次数据进行的横断面研究。Covitel 研究采用聚类抽样,通过固定电话和手机上的随机数字拨号,对 18 岁及以上的人群进行抽样。“COVID-19 诊断”的结果基于通过实验室检测或医疗诊断报告的确诊病例的自我报告。那些报告 COVID-19 的人被问及因 COVID-19 住院的需求。自变量包括性别、年龄、教育程度、地区、合并症、私人医疗保险计划、自我评估的健康状况和就业状况。使用逻辑回归模型估计比值比,考虑到复杂的样本设计。

结果

在 9000 人的样本中,COVID-19 诊断的流行率为 25.4%(95%CI 23.8-27.1%),从东北地区的 23.0%(95%CI 20.0-26.3%)到南部地区的 28.5%(95%CI 25.3-31.7%)不等。中年成年人(35-44 岁)COVID-19 诊断的流行率最高。教育程度越高,COVID-19 诊断的流行率越高。

结论

COVID-19 诊断的流行率在人群水平上与 SARS-CoV-2 感染显著不同。获得检测的社会经济差异可能是原因。在巴西,老年患者和合并症患者因 COVID-19 住院的可能性更高。

相似文献

1
COVID-19 diagnosis and hospital admissions in Brazil: a countrywide survey (Covitel, 2022).巴西的 COVID-19 诊断和住院情况:一项全国性调查(Covitel,2022 年)。
Rev Bras Epidemiol. 2024 Nov 22;27:e240052. doi: 10.1590/1980-549720240052. eCollection 2024.
2
A post-pandemic snapshot of the magnitude of COVID-19 in Brazil: A countrywide study.巴西新冠疫情规模的大流行后概况:一项全国性研究。
Braz J Infect Dis. 2025 Jan-Feb;29(1):104496. doi: 10.1016/j.bjid.2024.104496. Epub 2024 Dec 21.
3
Abusive consumption of alcoholic beverages: results from COVITEL, the Telephone Survey of Risk and Protective Factors for Noncommunicable Chronic Diseases, 2022 and 2023.酒精饮料的滥用消费:来自COVITEL的结果,即2022年和2023年非传染性慢性病风险与保护因素电话调查。
Rev Bras Epidemiol. 2025 Feb 24;28:e250009. doi: 10.1590/1980-549720250009. eCollection 2025.
4
Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data.巴西 25 万例 COVID-19 住院患者的特征:全国范围内数据的回顾性分析。
Lancet Respir Med. 2021 Apr;9(4):407-418. doi: 10.1016/S2213-2600(20)30560-9. Epub 2021 Jan 15.
5
SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.巴西的 SARS-CoV-2 抗体流行率:两项连续全国血清学家庭调查结果。
Lancet Glob Health. 2020 Nov;8(11):e1390-e1398. doi: 10.1016/S2214-109X(20)30387-9. Epub 2020 Sep 23.
6
COVID-19 in a state of Brazilian Northeast: Prevalence and associated factors in people with flu-like syndrome.巴西东北部的 COVID-19 疫情:流感样综合征患者的患病率及相关因素。
J Clin Nurs. 2020 Nov;29(21-22):4343-4348. doi: 10.1111/jocn.15472. Epub 2020 Sep 15.
7
Clinical-Epidemiological Profile of COVID-19 Patients Admitted during Three Waves of the Pandemic in a Tertiary Care Center, in Belém, Pará, Amazon Region of Brazil.巴西亚马逊地区贝伦市一家三级护理中心在三次大流行浪潮期间收治的 COVID-19 患者的临床流行病学特征。
Viruses. 2024 Jul 31;16(8):1233. doi: 10.3390/v16081233.
8
Sociodemographic factors associated with COVID-19 in-hospital mortality in Brazil.与巴西 COVID-19 院内死亡率相关的社会人口学因素。
Public Health. 2021 Mar;192:15-20. doi: 10.1016/j.puhe.2021.01.005. Epub 2021 Jan 15.
9
High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.巴西圣保罗一家大型大学附属医院出现症状的医护人员中 SARS-CoV-2 感染的高流行率。
BMC Infect Dis. 2020 Dec 2;20(1):917. doi: 10.1186/s12879-020-05662-8.
10
Factors associated with COVID-19 hospital deaths in Espírito Santo, Brazil, 2020.2020年巴西圣埃斯皮里图州与新冠病毒病医院死亡相关的因素
Epidemiol Serv Saude. 2020 Sep 25;29(4):e2020413. doi: 10.1590/S1679-49742020000400022. eCollection 2020.

本文引用的文献

1
[Telephone Survey of Risk Factors for Chronic Noncommunicable Diseases During the Pandemic (Covitel): methodological aspects].[大流行期间慢性非传染性疾病风险因素的电话调查(Covitel):方法学方面]
Cad Saude Publica. 2023 Sep 25;39(9):e00248922. doi: 10.1590/0102-311XPT248922. eCollection 2023.
2
Global inequities in access to COVID-19 health products and technologies: A political economy analysis.全球在获取 COVID-19 卫生产品和技术方面的不平等:政治经济学分析。
Health Place. 2023 Sep;83:103051. doi: 10.1016/j.healthplace.2023.103051. Epub 2023 Jun 8.
3
Barriers to and strategies to address COVID-19 testing hesitancy: a rapid scoping review.
新冠病毒检测犹豫的障碍及应对策略:快速范围综述。
BMC Public Health. 2022 Apr 14;22(1):750. doi: 10.1186/s12889-022-13127-7.
4
Systemic arterial hypertension as a risk factor for the severe form of covid-19: scoping review.系统性动脉高血压是 COVID-19 严重形式的一个风险因素:范围综述。
Rev Saude Publica. 2022 Apr 8;56:20. doi: 10.11606/s1518-8787.2022056004311. eCollection 2022.
5
Increasing trends in obesity prevalence from 2013 to 2019 and associated factors in Brazil.巴西 2013 年至 2019 年肥胖患病率的上升趋势及相关因素。
Rev Bras Epidemiol. 2021 Dec 10;24(suppl 2):e210009. doi: 10.1590/1980-549720210009.supl.2. eCollection 2021.
6
A systematic review of racial/ethnic and socioeconomic disparities in COVID-19.一项关于 COVID-19 中种族/民族和社会经济差异的系统评价。
Int J Equity Health. 2021 Nov 24;20(1):248. doi: 10.1186/s12939-021-01582-4.
7
Ethnic minority status as social determinant for COVID-19 infection, hospitalisation, severity, ICU admission and deaths in the early phase of the pandemic: a meta-analysis.少数民族身份是 COVID-19 感染、住院、严重程度、重症监护病房入院和死亡的社会决定因素:一项荟萃分析。
BMJ Glob Health. 2021 Nov;6(11). doi: 10.1136/bmjgh-2021-007433.
8
Effect of socioeconomic inequalities and vulnerabilities on health-system preparedness and response to COVID-19 in Brazil: a comprehensive analysis.巴西社会经济不平等和脆弱性对新冠疫情防控准备和应对的影响:一项综合分析。
Lancet Glob Health. 2021 Jun;9(6):e782-e792. doi: 10.1016/S2214-109X(21)00081-4. Epub 2021 Apr 12.
9
Testing COVID-19 in Brazil: fragmented efforts and challenges to expand diagnostic capacity at the Brazilian Unified National Health System.巴西的 COVID-19 检测:巴西统一国家卫生系统扩大诊断能力的分散努力和挑战。
Cad Saude Publica. 2021 Apr 7;37(3):e00277420. doi: 10.1590/0102-311X00277420. eCollection 2021.
10
Disparities in SARS-CoV-2 Testing in Massachusetts During the COVID-19 Pandemic.马萨诸塞州在 COVID-19 大流行期间的 SARS-CoV-2 检测中的差异。
JAMA Netw Open. 2021 Feb 1;4(2):e2037067. doi: 10.1001/jamanetworkopen.2020.37067.